Daniel Lee

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Hodgkin Lymphoma

Locally Advanced

Endometrial Cancer

Advanced Non Small Cell Lung Cancer

Top Venues

Cancer immunology research

Clinical cancer research : an official journal of the American Association for Cancer Research

Case reports in oncological medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Han Zhang, Sanghoon Lee, Renee R Muthakana, Binfeng Lu, David N Boone, Daniel Lee, Xiao-Song Wang
Intragenic Rearrangement Burden Associates with Immune Cell Infiltration and Response to Immune Checkpoint Blockade in Cancer. Cancer immunology research 12 (3) (2024)
William F Maguire, Daniel Lee, Chana Weinstock, Xin Gao, Catharine C Bulik, Sundeep Agrawal, Elaine Chang, Salaheldin S Hamed, Erik W Bloomquist, Shenghui Tang, Richard Pazdur, Paul G Kluetz, Laleh Amiri-Kordestani, Daniel L Suzman
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
William F Maguire, Daniel Lee, Chana Weinstock, Xin Gao, Catharine C Bulik, Sundeep Agrawal, Elaine Chang, Salaheldin S Hamed, Erik W Bloomquist, Shenghui Tang, Richard Pazdur, Paul G Kluetz, Laleh Amiri-Kordestani, Daniel L Suzman
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Han Zhang, Sanghoon Lee, Renee R Muthakana, Binfeng Lu, David N Boone, Daniel Lee, Xiao-Song Wang
Intragenic Rearrangement Burden Associates with Immune Cell Infiltration and Response to Immune Checkpoint Blockade in Cancer. Cancer immunology research 12 (3) (2024)
Han Zhang, Sanghoon Lee, Renee R Muthakana, Binfeng Lu, David N Boone, Daniel Lee, Xiao-Song Wang
Intragenic Rearrangement Burden Associates with Immune Cell Infiltration and Response to Immune Checkpoint Blockade in Cancer. Cancer immunology research 12 (3) (2024)
Han Zhang, Sanghoon Lee, Renee R Muthakana, Binfeng Lu, David N Boone, Daniel Lee, Xiao-Song Wang
Intragenic Rearrangement Burden Associates with Immune Cell Infiltration and Response to Immune Checkpoint Blockade in Cancer. Cancer immunology research (2024)
William F Maguire, Daniel Lee, Chana Weinstock, Xin Gao, Catharine C Bulik, Sundeep Agrawal, Elaine Chang, Salaheldin S Hamed, Erik W Bloomquist, Shenghui Tang, Richard Pazdur, Paul G Kluetz, Laleh Amiri-Kordestani, Daniel L Suzman
FDA Approval Summary: Enfortumab Vedotin plus Pembrolizumab for Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
William F Maguire, Daniel Lee, Chana Weinstock, Xin Gao, Catharine C Bulik, Sundeep Agrawal, Elaine Chang, Salaheldin S Hamed, Erik W Bloomquist, Shenghui Tang, Richard Pazdur, Paul G Kluetz, Laleh Amiri-Kordestani, Daniel L Suzman
FDA Approval Summary: Enfortumab Vedotin Plus Pembrolizumab for Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Han Zhang, Sanghoon Lee, Renee R Muthakana, Binfeng Lu, David N Boone, Daniel Lee, Xiao-Song Wang
Intragenic Rearrangement Burden Associates with Immune Cell Infiltration and Response to Immune Checkpoint Blockade in Cancer. Cancer immunology research 12 (3) (2024)
Han Zhang, Sanghoon Lee, Renee R Muthakana, Binfeng Lu, David N Boone, Daniel Lee, Xiao-Song Wang
Intragenic Rearrangement Burden Associates with Immune Cell Infiltration and Response to Immune Checkpoint Blockade in Cancer. Cancer immunology research 12 (3) (2024)
Dayne Ashman, Gabriela Quiroga-Garza, Daniel Lee
Rare Presentation of Metastatic Lobular Breast Carcinoma Involving Clear Cell Renal Cell Carcinoma. Case reports in oncological medicine 2020 (2020)